Compound comparison
NAD+ vs MOTS-c
As of 2026-09-08, DMV Research compares NAD+ (CAS 53-84-9) and MOTS-c (CAS 1456083-98-9) across 13 identity and analytical axes, backed by 2 published third-party certificates of analysis, for laboratory research use only.
This page sets two research compounds beside each other on the facts DMV Research can evidence: registry identity, the assay each lot was tested by, and what the catalog currently lists. It states what each compound IS, not what it does, and it does not put one ahead of the other — both are supplied for laboratory research use only.
For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use. Not a drug, food, cosmetic, or dietary supplement.
NAD+ and MOTS-c, side by side
Every row is read from a published record — the compound guides for identity, the per-lot certificates for the analytical results, and the live catalog for price. A dash means the fact is not published for that compound, not that it is zero.
| Axis | NAD+ | MOTS-c |
|---|---|---|
| Structural class | Cellular Coenzyme | Mitochondrial Peptide |
| CAS number | 53-84-9 | 1456083-98-9 |
| Sequence length | — | — |
| Molecular formula | C21H27N7O14P2 | C17H28N8O13 |
| Also known as | Nicotinamide adenine dinucleotide, NAD, β-NAD+ | Mitochondrial Open Reading Frame of the 12S rRNA-c, Mitochondrial-derived peptide |
| Analytical method | Blend Purity & Quant (HPLC) | Blend Purity & Quant (HPLC) |
| Reported purity | 99.12% | 99.65% |
| Analysing laboratory | ILS Laboratories, San Diego, CA | ILS Laboratories, San Diego, CA |
| Lot on record | LOT-2026-001, analysed June 14, 2026 | LOT-2026-001, analysed June 15, 2026 |
| Formulation | Lyophilized · 1000 mg label claim · 1019.8 mg measured net content | Lyophilized · 40 mg label claim · 41.33 mg measured net content |
| Catalog availability | Listed as a standalone product | Listed as a standalone product |
| Current price | $85.00 USD | $129.00 USD |
| Sequence | — | MRWQEMGYIFYPRKLR |
Verify these figures
The purity, method, lot and date rows above are transcribed from certificates DMV Research publishes in full. Open the NAD+ certificate record and the MOTS-c certificate record to read each lot's own document, or the full certificate index for every lot currently held.
Identity data — CAS number, molecular formula and sequence — is the same data the NAD+ and MOTS-c guides publish, and the Research Use Only scope that governs both listings is stated in full.
Frequently asked questions
What is the structural difference between NAD+ and MOTS-c?
They are different classes of molecule with separate CAS registrations: NAD+ is a dinucleotide coenzyme (CAS 53-84-9), and MOTS-c is a 16-amino-acid mitochondrial-derived peptide (CAS 1456083-98-9).
Do NAD+ and MOTS-c share a CAS number?
No. NAD+ is CAS 53-84-9 and MOTS-c is CAS 1456083-98-9. A CAS registry number identifies one substance, so two different numbers are two different substances.
How is each compound analysed before it is listed?
Both are assayed by third-party laboratory testing for identity and purity, and the resulting per-batch certificate is published on this site.
Are NAD+ and MOTS-c both listed as standalone products at DMV Research?
Yes. Both are listed individually in the catalog, each with its own per-batch Certificate of Analysis.
Does this page say which compound to pick?
No. It compares registry identity, analytical results and catalog availability only. Both compounds are supplied for laboratory research use only, and this site publishes no guidance on use, effect, or suitability for any application.
Research use only
All products are intended for laboratory and research use only (RUO) and are not for human consumption, ingestion, or any in-vivo use.
The statements on this page have not been evaluated by the FDA. For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use. Not a drug, food, cosmetic, or dietary supplement.